ResearcherAffiliated Hospital of Xuzhou Medical CollegeNo recent work listed

Li Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3275-2499; OpenAlex author ID A5100418798. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper

Papers 1

Deubiquitinase USP9X promotes cell migration, invasion and inhibits apoptosis of human pancreatic cancer. Co-author DOI 10.3892/or.2017.6050 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yi Zhang · 1 shared paper, 2017 · strength 0.06
- Paper Deubiquitinase USP9X promotes cell migration, invasion and inhibits apoptosis of human pancreatic cancer. DOI 10.3892/or.2017.6050 ↗
Pengbo Zhang · 1 shared paper, 2017 · strength 0.06
- Paper Deubiquitinase USP9X promotes cell migration, invasion and inhibits apoptosis of human pancreatic cancer. DOI 10.3892/or.2017.6050 ↗
Zeqiang Ren · 1 shared paper, 2017 · strength 0.06
- Paper Deubiquitinase USP9X promotes cell migration, invasion and inhibits apoptosis of human pancreatic cancer. DOI 10.3892/or.2017.6050 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.